CIK 0001604821 · Large accelerated filer
Natera, Inc.
Sign in to watch- Ticker
- NTRA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 010894487
- Phone
- 650-249-9090
- Business address
- 13011 MCCALLEN PASS, BUILDING A SUITE 100, AUSTIN, TX, 78753
- Former names
- Natera, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $104,832,418
- in 28 filings, $104.8M under 10b5-1 plans
Net −$104,832,418. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Rabinowitz Matthew −$72.3M EXECUTIVE CHAIRMAN sold 9% of stake
- Sheena Jonathan −$13.8M Director sold 83% of stake
- Moshkevich Solomon −$9.5M PRESIDENT, CLINICALDIAGNOSTICS sold 21% of stake
- Chapman Steven Leonard −$5.0M CEO AND PRESIDENT sold 12% of stake
- Brophy Michael Burkes −$2.5M CHIEF FINANCIAL OFFICER sold 11% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-24 | ROSENMAN HERM Director | Sale 10b5-1 | −16,530 | $250.00 | $4.1M | 4,250 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −256 | $218.14 | $56K | 19,276 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −128 | $219.26 | $28K | 19,148 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −122 | $220.93 | $27K | 19,026 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −244 | $221.46 | $54K | 18,782 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −267 | $218.18 | $58K | 19,265 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −96 | $219.13 | $21K | 19,169 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −71 | $220.46 | $16K | 19,098 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −301 | $221.39 | $67K | 18,797 |
| 2026-06-17 | Sheena Jonathan Director | Sale 10b5-1 | −15 | $222.14 | $3K | 18,782 |
| 2026-06-16 | Chapman Rowan E Director | Sale 10b5-1 | −2,964 | $216.78 | $643K | 3,124 |
| 2026-06-15 | Sheena Jonathan Director | Sale 10b5-1 | −1,750 | $210.29 | $368K | 250,752 |
| 2026-06-15 | Sheena Jonathan Director | Sale 10b5-1 | −600 | $211.34 | $127K | 250,152 |
| 2026-06-15 | Sheena Jonathan Director | Sale 10b5-1 | −500 | $212.42 | $106K | 249,652 |
| 2026-06-15 | Sheena Jonathan Director | Sale 10b5-1 | −300 | $213.54 | $64K | 249,352 |
| 2026-06-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −831 | $209.83 | $174K | 2,327,012 |
| 2026-06-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,832 | $210.73 | $386K | 2,325,180 |
| 2026-06-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −1,237 | $211.81 | $262K | 2,323,943 |
| 2026-06-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −5,097 | $212.84 | $1.1M | 2,318,846 |
| 2026-06-15 | Rabinowitz Matthew EXECUTIVE CHAIRMAN | Sale 10b5-1 | −7,836 | $213.88 | $1.7M | 2,311,010 |
Page 15 of 39 · 767 trades